CIK 0001113169
TROW PRICE T ROWE GROUP INC
Insider trading from SEC Form 4. Last filing Dec 31, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
3
with a Form 4 at this company
Signals
Open-market buys and sells at PRICE T ROWE GROUP INC, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Congressional trades
2 trades in TROW disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Kevin Hern House · R-OK | Sale | TROW T. Rowe Price Group, Inc. - Common Stock | $15k to $50k | Mar 20, 2026 | 14 days after the trade |
| Julie Johnson House · D-TX | Sale | TROW T. Rowe Price Group, Inc. - Common Stock | $1,001 to $15k | Apr 1, 2025 | 43 days after the trade |
Transactions
The last 6 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 27, 2024 | DONNELLY WILLIAM P director | AGrant or award Common Stock | +63 | $115.67 | $7,341 | 5,984 | Dec 31, 2024 |
| Dec 27, 2024 | DUBLON DINA director | AGrant or award Common Stock | +95 | $115.67 | $11k | 12,649 | Dec 31, 2024 |
| Dec 30, 2024 | DONNELLY WILLIAM P director | AGrant or award Common Stock | +541 | $0.00 | $0 | 6,525 | Dec 31, 2024 |
| Dec 10, 2024 | Dardis Jennifer B other | FTax withholding Common Stock | -3,068 | $123.59 | $379k | 34,020 | Dec 11, 2024 |
| Dec 4, 2024 | Dardis Jennifer B other | AGrant or award Common Stock | +6,708 | $0.00 | $0 | 36,899 | Dec 6, 2024 |
| Dec 4, 2024 | Dardis Jennifer B other | AGrant or award Common Stock | +189 | $113.06 | $21k | 37,088 | Dec 6, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- DONNELLY WILLIAM Pdirector
- DUBLON DINAdirector
- Dardis Jennifer Bother
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.